A report published on CIDRAP (Center for Infectious Disease Research & Policy Academic Health Center — University of Minnesota) indicates that those taking common statin drugs are possibly protected somewhat from the inflamation caused by the flu and which is often the cause of death.
The preliminary information is that those already taking the cholesterol-lowering drugs in a certain age group are only half as likely to die from the influenza.
John McCormick is a reporter, /science/medical columnist and finance and social commentator, with 17,000+ bylined stories. Contact John through NewsBlaze.
